Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2006

VistaGen Therapeutics (VSTA) Announces 3 Significant Publications Supporting the Use of Embryonic Stem Cells for Drug Discovery and Development

VistaGen Therapeutics Inc., a biopharmaceutical company pioneering the use of embryonic stem cells as proprietary biological systems for discovery and development of novel drugs for the treatment of diabetes and neurological diseases, announced today three recent publications highlighting important advances … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

VistaGen Therapeutics (VSTA) Announces Positive AV-101 Preclinical Data Suggesting Potential for Parkinson’s Disease

VistaGen Therapeutics, Inc., a biopharmaceutical company developing drugs for treating neurological disorders and diabetes, announced today positive preclinical data supporting expanded applications of AV-101, the Company’s first in-class prodrug that regulates critical NMDA receptors in the brain. The studies, which … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment